跳至主要内容
临床试验/EUCTR2018-001705-91-DK
EUCTR2018-001705-91-DK进行中(未招募)1 期

MELADERM-trial: Melatonin cream against acute radiation dermatitis in patients with early breast cancer: a pivotal phase 2, double-blind, randomized, placebo-controlled trial

Center for Perioperative Optimization, Department of Surgery, Herlev Hospital0 个研究点目标入组 80 人开始时间: 2018年7月26日最近更新:
适应症

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
Female

入选标准

  • Diagnosed with early breast cancer
  • Over 49 years old
  • Have had radical tumor resection surgery
  • Follows treatment regimens and follow-up at Rigshospitalet
  • Written informed consent after written and verbal information
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 30
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 50

排除标准

  • Inability to understand Danish, written or spoken
  • Mental illness*
  • Previous therapy with ionizing radiation in the thoracic or neck area
  • Use of bolus for radiation therapy**
  • * Defined as having a diagnosis and being in medical treatment, or if anticipated poor compliance. ** A bolus is a material which has dose absorption properties equivalent to tissue. It is placed on the irradiated area to alter dosing or target of the radiation therapy

研究者

发起方
Center for Perioperative Optimization, Department of Surgery, Herlev Hospital

相似试验